SyneuRx First Five Subjects Randomized in SyneuRx’ SND12 PhaseIIb/III Study of Clozaben®, a Novel Traetment for Refractory Schizophrenia Posted on 2017-05-222021-02-07 by maxproadmin More >>
SyneuRx First Three Subjects Randomized in SyneuRx’s SND13 Phase IIb/III NaBen© Schizophrenia Trial Posted on 2017-05-112021-02-07 by maxproadmin More >>